サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1693247

医療用バイオミメティックスの世界市場レポート 2025年

Medical Biomimetics Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
医療用バイオミメティックスの世界市場レポート 2025年
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療用バイオミメティックス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.4％で506億8,000万米ドルに成長します。予測期間の成長は、臓器移植需要の増加、バイオミメティクス・アプリケーションの認知度向上、ヘルスケア支出の増加、バイオテクノロジー部門の拡大、組織工学の進歩などに起因すると考えられます。予測期間の主な動向には、バイオインスパイア人工装具、バイオミメティックセンサー、合成生物学アプリケーション、スマートドラッグデリバリーシステム、バイオインスパイアロボット、個別化医療、3Dプリンティング技術、診断における人工知能、ナノテクノロジーアプリケーション、再生医療などがあります。

肥満と心臓病の有病率の上昇が医療用バイオミメティックス市場の成長を牽引すると予想されます。肥満は過剰な体脂肪が不健康なレベルまで蓄積した状態であり、心臓病は心臓や血管に影響を及ぼす様々な状態を包含します。バイオミメティクスは、糖尿病や肥満などの症状を持つ人の健康管理を助ける装具や義肢などの補助器具の開発において重要な役割を果たしています。例えば、2022年8月、米国の非営利医療団体である米国心臓病学会（American College of Cardiology）の報告書は、2025年から2060年にかけて米国における4大心血管系危険因子すべての増加を予測しました。最も増加が予想されたのは糖尿病で、39.3％増の5,500万人、次いで脂質異常症（27.6％増の1億2,600万人）、高血圧（25.1％増の1億6,200万人）、肥満（18.3％増の1億2,600万人）と続いた。また、心血管疾患、特に脳卒中（33.8％→1,500万人）、心不全（33.4％→1,300万人）、虚血性心疾患（30.7％→2,900万人）、心臓発作（16.9％→1,600万人）の割合も大幅に増加しています。その結果、肥満と心臓病の増加率が医療用バイオミメティックス市場の拡大に寄与しています。

医療用バイオミメティックス市場で事業を展開する主要企業は、市場での収益性を高めるため、縫合糸アンカーシステムなどの先進技術を搭載した革新的な製品の開発に注力しています。縫合糸アンカーシステムは、整形外科やスポーツ医学の手術において、腱や靭帯などの軟部組織を骨に固定するために使用される医療機器です。縫合糸アンカーシステムは、軟部組織と骨との自然な結合を再現・改善することに努め、人体の生理的な組織結合を反映した、機能的かつ生体力学的に最適化されたソリューションを提供します。例えば、米国を拠点とする多国籍医療技術企業であるストライカー・コーポレーションは、2022年12月、使い捨ての縫合糸アンカー・システムであるシトレフィックスを発売しました。シトレフィックスは、骨化学を模倣するように特別に設計されたクエン酸ポリマーから作られたエラストマー材料であるシトレゲンを使用し、再吸収可能な生体模倣型アンカー本体を組み込んだものです。この設計により、慢性炎症を誘発することなく、吸収をコントロールすることができます。これは使い捨ての縫合糸アンカー・システムであり、整形外科手術に使用される場合、移植組織の治癒と健康な骨の成長を助けるように設計されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界医療用バイオミメティックス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の医療用バイオミメティックス市場：成長率分析
  • 世界の医療用バイオミメティックス市場の実績：規模と成長, 2019-2024
  • 世界の医療用バイオミメティックス市場の予測：規模と成長, 2024-2029, 2034F
  • 世界医療用バイオミメティックス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の医療用バイオミメティックス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心臓血管
  • 整形外科
  • 眼科
  • 歯科
  • その他のタイプ
  • 世界の医療用バイオミメティックス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 傷の治癒
  • 組織工学
  • ドラッグデリバリー
  • その他の用途
  • 世界の医療用バイオミメティックス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 専門クリニック
  • その他のエンドユーザー
  • 世界の医療用バイオミメティックス市場、心臓血管のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 血管移植
  • ステントと心臓弁
  • 心臓補助装置
  • 世界の医療用バイオミメティックス市場整形外科のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 骨移植
  • 関節置換インプラント
  • 脊椎インプラント
  • 世界の医療用バイオミメティックス市場眼科のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 人工角膜
  • 網膜インプラント
  • 眼内レンズ
  • 世界の医療用バイオミメティックス市場、歯科のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 歯科インプラント
  • 骨再生製品
  • 生体適合性材料
  • 世界の医療用バイオミメティックス市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 創傷治癒製品
  • 組織工学用足場
  • 神経学的デバイス

第7章 地域別・国別分析

  • 世界の医療用バイオミメティックス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の医療用バイオミメティックス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医療用バイオミメティックス市場：競合情勢
  • 医療用バイオミメティックス市場：企業プロファイル
    • BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Otsuka Medical Device Company Ltd.
  • LivaNova PLC
  • Ossur hf.
  • Forschungszentrum Julich GmbH
  • Biohorizons Implant Systems Inc.
  • Inventia Plc
  • Blatchford Limited
  • Keystone Dental Corporation
  • Xtant Medical Holdings Inc.
  • AVINENT Science and Technology
  • SynTouch Inc.
  • Curasan Inc.
  • CorNeat Vision Inc.
  • Hstar Technologies Co. Ltd.
  • Veryan Medical Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 医療用バイオミメティックス市場2029：新たな機会を提供する国
  • 医療用バイオミメティックス市場2029：新たな機会を提供するセグメント
  • 医療用バイオミメティックス市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r28487

Medical biomimetics refers to the development and application of innovative technologies that replicate and enhance natural physiological processes, aiming to create functional and biomechanically optimized solutions in the field of healthcare. Medical biomimetics plays a crucial role in advancing the field of artificial organs and tissues. It is extensively employed in the design of drug delivery systems that emulate biological processes, improving the precision and efficiency of targeted medication delivery.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

The medical biomimetics market size has grown strongly in recent years. It will grow from $36.6 billion in 2024 to $39.56 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increased biomimetic materials, increased research funding, aging population, rising chronic diseases.

The medical biomimetics market size is expected to see strong growth in the next few years. It will grow to $50.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing demand for organ transplants, growing awareness of biomimetics applications, rising healthcare expenditure, expanding biotechnology sector, advancements in tissue engineering. Major trends in the forecast period include Bio-inspired prosthetics, biomimetic sensors, synthetic biology applications, smart drug delivery systems, biologically inspired robotics, Personalized medicine, 3D printing technologies, artificial intelligence in diagnostics, nanotechnology applications, regenerative medicine.

The rising prevalence of obesity and heart disease is expected to drive the growth of the medical biomimetics market. Obesity is a condition in which excess body fat accumulates to unhealthy levels, while heart disease encompasses a variety of conditions that affect the heart and blood vessels. Biomimetics plays a crucial role in developing assistive devices, such as orthotics and prosthetics, that can help individuals with conditions like diabetes or obesity manage their health. For example, in August 2022, a report by the American College of Cardiology, a US-based non-profit medical association, projected an increase in all four major cardiovascular risk factors in the United States from 2025 to 2060. The largest rise was anticipated in diabetes, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The study also indicated significant increases in cardiovascular disease rates, particularly for stroke (33.8% to 15 million), heart failure (33.4% to 13 million), ischemic heart disease (30.7% to 29 million), and heart attack (16.9% to 16 million). As a result, the growing rates of obesity and heart disease are contributing to the expansion of the medical biomimetics market.

Major companies operating in the medical biomimetics market are focused on developing innovative products with advanced technologies, such as suture anchor system to increase their profitability in market. A suture anchor system is a medical device used in orthopedic and sports medicine procedures for securing soft tissues, such as tendons or ligaments, to bone. Suture anchor systems strive to replicate and improve upon the natural attachment of soft tissues to bone, offering a functional and biomechanically optimized solution mirroring physiological tissue connections in the human body. For instance, in December 2022, Stryker Corporation, a US-based multinational medical technologies company, launches Citrefix, a disposable suture anchor system, incorporates a resorbable biomimetic anchor body using Citregen, an elastomeric material crafted from a citrate polymer, specifically engineered to emulate bone chemistry. This design allows for controlled resorption without inducing chronic inflammation. It is a disposable suture anchor system that is designed to help grafted tissue heal and healthy bone grow when used in orthopedic surgical applications.

In July 2024, Edwards Lifesciences, a US-based medical technology company, acquired Innovalve Bio Medical for $300 million. This acquisition allows Edwards to reinforce its position in the expanding market for TMVR devices, which is expected to experience significant growth in the coming years. Innovalve Bio Medical is an Israel-based provider of medical biomimetics.

Major companies operating in the medical biomimetics market are BASF SE, Bayer Aktiengesellschaft, Abbott Laboratories, Stryker Corporation, Zimmer Biomet Holdings Inc., Otsuka Medical Device Company Ltd., LivaNova PLC, Ossur hf., Forschungszentrum Julich GmbH, Biohorizons Implant Systems Inc., Inventia Plc, Blatchford Limited, Keystone Dental Corporation, Xtant Medical Holdings Inc., AVINENT Science and Technology, SynTouch Inc., Curasan Inc., CorNeat Vision Inc., Hstar Technologies Co. Ltd., Veryan Medical Ltd., Swedish Biomimetics 3000 ApS, Osteopore International Pte Ltd., KitoTech Medical Ltd., Vandstrom Inc.

North America was the largest region in the medical biomimetics market in 2024. The regions covered in the medical biomimetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical biomimetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical biomimetics market consists of sales of diagnostic tools, wound healing products, bio-inspired robotics, bioelectronic devices and regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Biomimetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical biomimetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical biomimetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical biomimetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cardiovascular; Orthopedic; Ophthalmology; Dental; Other Types
  • 2) By Application: Wound Healing; Tissue Engineering; Drug Delivery; Other Applications
  • 3) By End User: Hospitals; Specialty Clinics; Other End Users
  • Subsegments:
  • 1) By Cardiovascular: Vascular Grafts; Stents and Heart Valves; Cardiac Assist Devices
  • 2) By Orthopedic: Bone Grafts; Joint Replacement Implants; Spinal Implants
  • 3) By Ophthalmology: Artificial Corneas; Retinal Implants; Intraocular Lenses
  • 4) By Dental: Dental Implants; Bone Regeneration Products; Biocompatible Materials
  • 5) By Other Types: Wound Healing Products; Tissue Engineering Scaffolds; Neurological Devices
  • Companies Mentioned: BASF SE; Bayer Aktiengesellschaft; Abbott Laboratories; Stryker Corporation; Zimmer Biomet Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Biomimetics Market Characteristics

3. Medical Biomimetics Market Trends And Strategies

4. Medical Biomimetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Medical Biomimetics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Medical Biomimetics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Medical Biomimetics Market Growth Rate Analysis
  • 5.4. Global Medical Biomimetics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Medical Biomimetics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Medical Biomimetics Total Addressable Market (TAM)

6. Medical Biomimetics Market Segmentation

  • 6.1. Global Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Other Types
  • 6.2. Global Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Other Applications
  • 6.3. Global Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End Users
  • 6.4. Global Medical Biomimetics Market, Sub-Segmentation Of Cardiovascular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vascular Grafts
  • Stents and Heart Valves
  • Cardiac Assist Devices
  • 6.5. Global Medical Biomimetics Market, Sub-Segmentation Of Orthopedic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Grafts
  • Joint Replacement Implants
  • Spinal Implants
  • 6.6. Global Medical Biomimetics Market, Sub-Segmentation Of Ophthalmology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Artificial Corneas
  • Retinal Implants
  • Intraocular Lenses
  • 6.7. Global Medical Biomimetics Market, Sub-Segmentation Of Dental, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dental Implants
  • Bone Regeneration Products
  • Biocompatible Materials
  • 6.8. Global Medical Biomimetics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wound Healing Products
  • Tissue Engineering Scaffolds
  • Neurological Devices

7. Medical Biomimetics Market Regional And Country Analysis

  • 7.1. Global Medical Biomimetics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Medical Biomimetics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Biomimetics Market

  • 8.1. Asia-Pacific Medical Biomimetics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Biomimetics Market

  • 9.1. China Medical Biomimetics Market Overview
  • 9.2. China Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Biomimetics Market

  • 10.1. India Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Biomimetics Market

  • 11.1. Japan Medical Biomimetics Market Overview
  • 11.2. Japan Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Biomimetics Market

  • 12.1. Australia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Biomimetics Market

  • 13.1. Indonesia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Biomimetics Market

  • 14.1. South Korea Medical Biomimetics Market Overview
  • 14.2. South Korea Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Biomimetics Market

  • 15.1. Western Europe Medical Biomimetics Market Overview
  • 15.2. Western Europe Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Biomimetics Market

  • 16.1. UK Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Biomimetics Market

  • 17.1. Germany Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Biomimetics Market

  • 18.1. France Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Biomimetics Market

  • 19.1. Italy Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Biomimetics Market

  • 20.1. Spain Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Biomimetics Market

  • 21.1. Eastern Europe Medical Biomimetics Market Overview
  • 21.2. Eastern Europe Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Biomimetics Market

  • 22.1. Russia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Biomimetics Market

  • 23.1. North America Medical Biomimetics Market Overview
  • 23.2. North America Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Biomimetics Market

  • 24.1. USA Medical Biomimetics Market Overview
  • 24.2. USA Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Biomimetics Market

  • 25.1. Canada Medical Biomimetics Market Overview
  • 25.2. Canada Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Biomimetics Market

  • 26.1. South America Medical Biomimetics Market Overview
  • 26.2. South America Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Biomimetics Market

  • 27.1. Brazil Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Biomimetics Market

  • 28.1. Middle East Medical Biomimetics Market Overview
  • 28.2. Middle East Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Biomimetics Market

  • 29.1. Africa Medical Biomimetics Market Overview
  • 29.2. Africa Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Biomimetics Market Competitive Landscape And Company Profiles

  • 30.1. Medical Biomimetics Market Competitive Landscape
  • 30.2. Medical Biomimetics Market Company Profiles
    • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Medical Biomimetics Market Other Major And Innovative Companies

  • 31.1. Otsuka Medical Device Company Ltd.
  • 31.2. LivaNova PLC
  • 31.3. Ossur hf.
  • 31.4. Forschungszentrum Julich GmbH
  • 31.5. Biohorizons Implant Systems Inc.
  • 31.6. Inventia Plc
  • 31.7. Blatchford Limited
  • 31.8. Keystone Dental Corporation
  • 31.9. Xtant Medical Holdings Inc.
  • 31.10. AVINENT Science and Technology
  • 31.11. SynTouch Inc.
  • 31.12. Curasan Inc.
  • 31.13. CorNeat Vision Inc.
  • 31.14. Hstar Technologies Co. Ltd.
  • 31.15. Veryan Medical Ltd.

32. Global Medical Biomimetics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Biomimetics Market

34. Recent Developments In The Medical Biomimetics Market

35. Medical Biomimetics Market High Potential Countries, Segments and Strategies

  • 35.1 Medical Biomimetics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Medical Biomimetics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Medical Biomimetics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer